ClearPoint Neuro (CLPT) Non-Current Deffered Revenue (2018 - 2026)
ClearPoint Neuro (CLPT) posted Non-Current Deffered Revenue of $608000.0 for Q1 2026, up 4.65% sequentially from $581000.0 in Q4 2025, and up 70.31% YoY from $357000.0 in Q1 2025.
ClearPoint Neuro (CLPT) Non-Current Deffered Revenue (2018 - 2026) Analysis & Trends
ClearPoint Neuro has reported Non-Current Deffered Revenue for 9 years, with the latest figure at $608000.0 in Q1 2026.
- Quarterly Non-Current Deffered Revenue rose 70.31% year-over-year to $608000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $608000.0 (up 70.31% YoY) and the FY2025 annual result came in at $581000.0, up 33.26% from the prior year.
- Non-Current Deffered Revenue rose to $608000.0 in Q1 2026 per CLPT's latest filing, from $581000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $769000.0 in Q3 2025 and troughed at $253000.0 in Q2 2023.
- A 5-year average of $466235.3 and a median of $446000.0 in 2024 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2023 and 2024: Non-Current Deffered Revenue tumbled 36.91% in 2023, then jumped 76.28% in 2024.
- Over 5 years, Non-Current Deffered Revenue stood at $390000.0 in 2022, then jumped by 38.72% to $541000.0 in 2023, then slipped by 19.41% to $436000.0 in 2024, then surged by 33.26% to $581000.0 in 2025, then increased by 4.65% to $608000.0 in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $608000.0, $581000.0, and $769000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | ClearPoint Neuro | 460.04 Mn | 430.64 Mn | 6.71 Mn | 511,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 511,000.00 |
| Mar 31, 2026 | 608,000.00 |
| Dec 31, 2025 | 581,000.00 |
| Sep 30, 2025 | 769,000.00 |
| Jun 30, 2025 | 603,000.00 |
| Mar 31, 2025 | 357,000.00 |
| Dec 31, 2024 | 436,000.00 |
| Sep 30, 2024 | 480,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Mar 31, 2024 | 458,000.00 |
| Dec 31, 2023 | 541,000.00 |
| Sep 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 253,000.00 |
| Mar 31, 2023 | 320,000.00 |
| Dec 31, 2022 | 390,000.00 |
| Sep 30, 2022 | 351,000.00 |
| Jun 30, 2022 | 401,000.00 |
| Mar 31, 2022 | 408,000.00 |
| Dec 31, 2021 | 264,000.00 |
| Sep 30, 2021 | 310,000.00 |